Ropes Wealth Advisors’s GSK GSK Stock Holding History

Ropes Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,118	Closed	-$97K	–	461
2020 Q4	$97K	Sell	2,118 -1,400	-40%	-$64.3K	0.02%	320
2020 Q3	$166K	Sell	3,518 -40	-1%	-$2K	0.03%	217
2020 Q2	$181K	Buy	3,558 +80	+2%	+$4.1K	0.04%	200
2020 Q1	$165K	Hold	3,478	–	–	0.04%	186
2019 Q4	$204K	Buy	3,478 +800	+30%	+$44.5K	0.04%	209
2019 Q3	$143K	Hold	2,678	–	–	0.03%	249
2019 Q2	$134K	Hold	2,678	–	–	0.03%	255
2019 Q1	$140K	Buy	2,678 +480	+22%	+$24K	0.04%	246
2018 Q4	$105K	Hold	2,198	–	–	0.03%	259
2018 Q3	$110K	Hold	2,198	–	–	0.03%	272
2018 Q2	$111K	Hold	2,198	–	–	0.03%	276
2018 Q1	$107K	Buy	2,198 +560	+34%	+$26.1K	0.03%	265
2017 Q4	$73K	Sell	1,638 -437	-21%	-$20.2K	0.02%	308
2017 Q3	$105K	Sell	2,075 -1,100	-35%	-$55.8K	0.03%	265
2017 Q2	$171K	Hold	3,175	–	–	0.05%	228
2017 Q1	$167K	Sell	3,175 -345	-10%	-$17.5K	0.05%	231
2016 Q4	$169K	Hold	3,520	–	–	0.05%	219
2016 Q3	$190K	Hold	3,520	–	–	0.06%	197
2016 Q2	$191K	Buy	3,520 +345	+11%	+$18.2K	0.07%	186
2016 Q1	$161K	Hold	3,175	–	–	0.07%	162
2015 Q4	$160K	Sell	3,175 -3,200	-50%	-$163K	0.07%	167
2015 Q3	$306K	Buy	6,375 +2,843	+80%	+$148K	0.16%	105
2015 Q2	$184K	Hold	3,532	–	–	0.1%	125
2015 Q1	$204K	Buy	+3,532	New	+$202K	0.11%	122

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Ropes Wealth Advisors's GSK Position: Q1 2021 in Review

Ropes Wealth Advisors sold out of GSK (GSK) in Q1 2021, closing a stake of 2,118 shares — an estimated $97K sold.

Ropes Wealth Advisors first reported a position in GSK in Q1 2015 and held it in 24 quarters. The position peaked at $306K in Q3 2015. 774 funds tracked by Wall St. Rank hold GSK as of Q1 2021.

Ropes Wealth Advisors reported no remaining GSK position as of Q1 2021 after selling out during the quarter.
Ropes Wealth Advisors sold 2,118 GSK shares in Q1 2021, an estimated $97K.
Ropes Wealth Advisors first reported a position in GSK in Q1 2015 and held it in 24 quarters.
Ropes Wealth Advisors's GSK position peaked at $306K in Q3 2015.
774 funds tracked by Wall St. Rank held GSK as of Q1 2021.

Based on Ropes Wealth Advisors's 13F filing for Q1 2021, filed 12 May 2021.